Prof. Davy CHENG

Founding Dean & Presidential Chair Professor, CUHK-Shenzhen Medicine

As a clinician-scientist, clinician-educator, and clinician-administrator, Prof. Cheng has authored over 190 peer-reviewed scientific articles, 60 books/book chapters (citations: 25,209; h-index: 69; i10-index: 149). His evidence-based guideline work and pioneer research in fast-track cardiac anesthesia and surgery has placed him among the World’s Top 2% Scientists since 2022; also #17 Global Ranking of Lifetime Highly Ranked Scholar in Anesthesiology (Tracheal Intubation) in 2024. Prof. Cheng has been a well sought-after speaker at over 220 universities, cardiac centers, and national/international conferences.

Dr. Keith W. H. CHIU

Consultant, Department of Diagnostic and Interventional Radiology, Queen Elizabeth Hospital

Dr. Keith Chiu is a Consultant in the Department of Diagnostic and Interventional Radiology, Queen Elizabeth Hospital. Dr. Chiu underwent his radiology training in the United Kingdom before returning back to Hong Kong in 2015, first as Clinical Assistant Professor in the Department of Diagnostic Radiology in the University of Hong Kong, then Associate Consultant in the department of Diagnostic and Interventional Radiology in Kwong Wah Hospital before his current post in 2022. Dr. Chiu has interests in Artificial Intelligence, oncological and intervention radiology with presentations, invited lectures and publications on related fields.

Prof. Andy CHUN

Professor of Practice, Department of Computing, The Hong Kong Polytechnic University

Prof. Andy Chun is a distinguished pioneer in Artificial Intelligence, with a career spanning several decades. He spearheaded Hong Kong’s first commercial AI system deployment in the late 1980s. He has since developed innovative AI solutions for numerous public and private sectors, significantly enhancing Hong Kong's social services, quality of life, and economic prosperity. Prof. Chun is a Professor of Practice at Hong Kong Polytechnic University and an Adjunct Professor of the EMBA program at City University of Hong Kong. In these roles, he actively advocates for innovation and the adoption of emerging technologies.

Throughout his career, Prof. Chun has led technology initiatives at Prudential plc, held CEO positions at multiple AI start-ups, and served as the University CIO at City University of Hong Kong. He is an advisor to the HKSAR Government on AI and IT strategies and the founder of the AI Specialist Group for the Hong Kong Computer Society. His exceptional contributions to AI have earned him numerous accolades, including being named a Distinguished Fellow of the Hong Kong Computer Society. Prof. Chun holds a Ph.D. in Electrical Engineering from the University of Illinois at Urbana-Champaign.

Prof. Gary K. K. LAU

Assistant Dean (Education Innovations), LKS Faculty of Medicine, The University of Hong Kong

Professor Gary Lau is currently Assistant Dean (Education Innovations), Director of EdTech and SIMHSE (Students in Medical and Health Sciences Education) and Director of HKU Stroke at HKUMed. He is also Honorary Consultant Neurologist at Queen Mary Hospital. He has published >180 articles/book chapters on stroke and have developed a number of innovative platforms to improve the prevention and holistic management of stroke. Professor Lau is also passionate in health sciences education. He and his team has pioneered a number of initiatives relating to EdTech and students as partners. He has received numerous prestigious awards which include the Henry Walton Prize from the Association for the Study of Medical Education, Exemplary Teaching and Learning Silver Award from eLearning Forum Asia, and Teaching Innovation Team Award from the University of Hong Kong. He was recognised as one of the Ten Outstanding Young Persons of Hong Kong in 2024.

Prof. Joseph J. Y. SUNG

Senior Vice President (Health & Life Sciences) and Dean of the Lee Kong Chian School of Medicine, Nanyang Technological University

Professor Sung is currently a Distinguished University Professor, Senior Vice President (Health & Life Sciences), and Dean of the Lee Kong Chian School of Medicine at Nanyang Technological University, Singapore. He obtained his medical degree (MBBS) from The University of Hong Kong and was awarded a PhD in Biomedical Sciences by the University of Calgary and an MD by The Chinese University of Hong Kong. From 2010 to 2017, he served as the Vice-Chancellor and President of The Chinese University of Hong Kong.

Professor Sung's research interests include intestinal bleeding, Helicobacter pylori, peptic ulcers, hepatitis B, colorectal cancer, and other cancers of the digestive system. In recent years, his work has expanded to studies on the gut microbiome, digestive diseases, and the application of artificial intelligence in clinical medicine. He has authored over 1,000 scientific articles published in leading medical and scientific journals. His most recent book, “Artificial Intelligence in Medicine: From Ethical, Social, and Legal Perspectives”, was published in 2024. Professor Sung has been recognized as a "Highly Cited Researcher" by Clarivate Analytics for the consecutive years from 2018 to 2024.

Dr. Xiaodong TAO

CEO, iFLYTEK Health

Xiaodong Tao, graduated from University of Science and Technology of China with a B.S. degree in Electrical Engineering. In 2005, he obtained his Ph.D. degree in Electrical and Computer Engineering from the Johns Hopkins University. Since then, he worked in General Electric Company and Royal Philips Electronics of the Netherlands, where he led teams working on research and development of cutting-edge technologies for healthcare and medical equipment, in particular, imaging devices, imaging methods, clinical applications, and radiology solutions. Dr. Tao joined iFLYTEK Health in Jan. 2017 as the CEO. In 2021, The University of Science and Technology of China hired him as the doctoral tutor of biomedical engineering.

Ms. Katy YEUNG

Partner, Howse Williams

Katy qualified as a Solicitor in England and Wales in 2011 and was admitted as a Hong Kong Solicitor in 2015. Katy is experienced in medico-legal matters. She advises healthcare professionals, clinics, private hospitals and their indemnity providers on a wide range of matters including clinical negligence claims, complaints, Coroner's inquests and disciplinary proceedings. Katy also advises on non-contentious matters on the Personal Data (Privacy) Ordinance, the Human Reproductive Technology Ordinance, and general compliance with the relevant codes and practices for healthcare professionals, clinics and private hospitals.

Nick Therkelsen

Former Founder and CEO, Bain-acquired AI/ML firm, Max Kelsen

Nick Therkelsen is the global leader for Healthcare AI at Bain & Company. Nick works with his clients to apply AI and Generative AI technology to their businesses. In particular, he works with healthcare and life sciences companies to support them through the disruption that technology is bringing to the sector. Nick has experience applying AI in genomics, drug discovery, diagnostics, clinical operations, commercial operations and more across medical devices, pharma and providers. Prior to Bain, Nick founded and was the CEO of leading Artificial Intelligence consultancy Max Kelsen, where he worked across sectors to build and deploy over 100 AI systems. Nick's team was awarded a global customer of the year award from Google and an AI & ML partner of the year award from Amazon Web Services, and they were published multiple times in top-tier academic journals, among other achievements. Nick holds a Bachelor of Laws with Honours and a Bachelor of Economics from the University of Queensland. In his personal time, Nick is an active investor in AI, HealthTech and BioTech startups.